Dihydrostreptomycin sulfate is a semisynthetic aminoglycoside antibiotic derived from streptomycin that functions as a bactericidal agent used to treat tuberculosis and various other mycobacterial infections.… Read more
Dihydrostreptomycin sulfate is a semisynthetic aminoglycoside antibiotic derived from streptomycin that functions as a bactericidal agent used to treat tuberculosis and various other mycobacterial infections. Pharmaceutical laboratories rely on accurate reference standards for Dihydrostreptomycin sulfate, along with its associated pharmacopeial and non-pharmacopeial impurities, to ensure rigorous quality control and regulatory compliance. These related compounds are essential for developing robust analytical methods, such as impurity profiling and quantitation, which are necessary to monitor the purity and stability of the active pharmaceutical ingredient. Utilizing high-quality reference standards and stable isotope labelled compounds facilitates precise method validation and helps ensure the safety and efficacy of the final drug product throughout the manufacturing process.